Frequently Asked Questions

We are at 587 Fifth Avenue, Suite 802, in midtown Manhattan - steps from Rockefeller Center and easily reached by subway, bus, and commuter rail.

Yes. Trial participation complements, but does not replace, your regular medical care. With your permission, we can also keep your personal physician informed of your participation.

Complete our brief, confidential pre-screening form or call us at (212) 772-3570. A member of our recruitment team will follow up, usually within one business day.

Yes. Your personal health information is protected in accordance with HIPAA and applicable privacy laws. Study data shared with sponsors is coded and does not identify you by name.

Yes. Participation is completely voluntary, and you may withdraw from a study at any time, for any reason, without penalty and without affecting your future care.

It depends on the study. Some trials compare a new treatment to a placebo (an inactive look-alike); others compare it to an existing treatment. Whether a placebo is used, and your chances of receiving it, will be clearly explained during informed consent before you decide to join.

No. Health insurance is not required to take part in a clinical trial at FCR.

There is no cost to you. Study-related visits, exams, and investigational medication are provided at no charge. Most studies also compensate participants for their time and travel; the amount varies by study and will be explained before you enroll.

A clinical trial is a carefully monitored research study that evaluates whether a new medication or treatment is safe and effective. Every trial at Fieve Clinical Research follows a protocol reviewed and approved by an independent review board (IRB), and participation is always voluntary.

Your safety comes first. Before joining, you will go through an informed consent process where a physician explains the study, its possible risks and benefits, and answers all of your questions. At FCR, every study visit is conducted by a board-certified physician, and your health is monitored closely throughout the trial.

Our core specialties are psychiatry and pain management/neurology (Phases II–IV, outpatient), and we selectively evaluate protocols in other areas that align with our physician expertise and patient population. Submit a protocol via our sponsor inquiry form — we respond within one business day.

We work exclusively with a central IRB and maintain an experienced regulatory team, allowing us to compress startup timelines.